Global Animal Biotechnology

Animal Biotechnology Comprehensive Study by Type (Animal Genomics, Animal Cloning, Genetic Engineering of Animals), Application (Preventive Care for Animals, Development of Animal Pharmaceuticals, Food Safety and Drug Development, Others), Products (Animal Products, Vaccines, Drugs, Others) Players and Region - Global Market Outlook to 2028

Animal Biotechnology Market by XX Submarkets | Forecast Years 2023-2028  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
What is Animal Biotechnology Market?

Animal biotechnology is a branch of biotechnology in which molecular biology techniques are used to genetically engineer living organisms in order to improve their suitability for pharmaceutical, agricultural or industrial applications. It involves all animals such as livestock, poultry, fish, insects, companion animals and laboratory animals. Animal biotechnology helps to improve animal health and welfare, advancement in human health, enhancements in animal products, environmental and conservation benefits. With the help of this technology, farmers can enhance breeding to produce healthier herds. It also helps to prevent and treat animal disease. Improved animal health results in safer foods for consumers. The animal products such as meat, milk and eggs can be nutritionally enriched with the use of this technology. It also helps to produce environmentally friendly animals as well as conserve endangered species.

Highlights from Animal Biotechnology Market Study
AttributesDetails
Study Period2018-2028
Base Year2022
UnitValue (USD Million)
Key Companies ProfiledRoche Holding AG (Switzerland), Bayer AG (Germany), Biogenesis Bago (Argentina), Boehringer Ingelheim (Germany), Merck & Co., Inc. (United States), Pfizer Inc. (United States), Santa Cruz Biotechnology, Inc. (United States), Virbac (France), Zoetis Inc. (United States) and Johnson & Johnson (United States)


Animal Biotechnology market is a fragmented market due to the presence of various players. Companies are focusing on developing innovative products and solutions to improve quality, enhances and promotes performance, along with try to incorporate latest technology. The companies are coming up with partnerships or agreements along with planning strategic activities such as partnerships, product launch, mergers, and acquisitions which will help them to sustain in the market and maintain their competitive edge. Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Animal Biotechnology market throughout the forecasted period.

Roche Holding AG (Switzerland), Bayer AG (Germany), Biogenesis Bago (Argentina), Boehringer Ingelheim (Germany), Merck & Co., Inc. (United States), Pfizer Inc. (United States), Santa Cruz Biotechnology, Inc. (United States), Virbac (France), Zoetis Inc. (United States) and Johnson & Johnson (United States) are some of the key players profiled in the study.

Animal Biotechnology Market Segmentation:
ScopeSub-Segments
Application / End UserPreventive Care for Animals, Development of Animal Pharmaceuticals, Food Safety and Drug Development and Others
TypeAnimal Genomics, Animal Cloning and Genetic Engineering of Animals
ProductsAnimal Products,Vaccines,Drugs,Others


On the basis of geography, the market of Animal Biotechnology has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Introduction of Use of Animal Organs in Human Transplant Operations

Market Growth Drivers:
Increased Applications of the Animal Biotechnology in Various Fields, Advancements in the Cloning and Development of Transgenic Animals, Rise in the Demand for Transgenic Animals and Increased Research and Development Activities

Challenges:
Introduction of Transgenic May Affect the Direction of Evolution and Eventually Decrease the Gene Pool

Restraints:
Transgenic Animals Are Costly To Produce and They Have High Value

Opportunities:
Favorable Government Policies for Animal Biotechnology Applications, Growing Demand from the Pharmaceutical Industry and Huge Investments by Major Players

Key Target Audience
Animal Biotechnology Companies, Research Professionals, Emerging Companies, Government Body & Associations and End-user

Market Leaders & Development Strategies

In Nov 2022, Biogénesis Bagó, the biotechnology company development, production and commercialization of solutions for animal health acquired biotech HIPRA's line of hormone products. This acquisition helped company to expand its presence in animal biotechnology market
In January 2008, the U.S. Food and Drug Administration (FDA) approved the sale of cloned animals and their offspring for food, despite fierce opposition from animal welfare and consumer advocacy groups, environmental organizations, some members of Congress, and many consumers.

Report Objectives / Segmentation Covered

By Type
  • Animal Genomics
  • Animal Cloning
  • Genetic Engineering of Animals
By Application
  • Preventive Care for Animals
  • Development of Animal Pharmaceuticals
  • Food Safety and Drug Development
  • Others
By Products
  • Animal Products
  • Vaccines
  • Drugs
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increased Applications of the Animal Biotechnology in Various Fields
      • 3.2.2. Advancements in the Cloning and Development of Transgenic Animals
      • 3.2.3. Rise in the Demand for Transgenic Animals
      • 3.2.4. Increased Research and Development Activities
    • 3.3. Market Challenges
      • 3.3.1. Introduction of Transgenic May Affect the Direction of Evolution and Eventually Decrease the Gene Pool
    • 3.4. Market Trends
      • 3.4.1. Introduction of Use of Animal Organs in Human Transplant Operations
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Animal Biotechnology, by Type, Application, Products and Region (value) (2017-2022)
    • 5.1. Introduction
    • 5.2. Global Animal Biotechnology (Value)
      • 5.2.1. Global Animal Biotechnology by: Type (Value)
        • 5.2.1.1. Animal Genomics
        • 5.2.1.2. Animal Cloning
        • 5.2.1.3. Genetic Engineering of Animals
      • 5.2.2. Global Animal Biotechnology by: Application (Value)
        • 5.2.2.1. Preventive Care for Animals
        • 5.2.2.2. Development of Animal Pharmaceuticals
        • 5.2.2.3. Food Safety and Drug Development
        • 5.2.2.4. Others
      • 5.2.3. Global Animal Biotechnology by: Products (Value)
        • 5.2.3.1. Animal Products
        • 5.2.3.2. Vaccines
        • 5.2.3.3. Drugs
        • 5.2.3.4. Others
      • 5.2.4. Global Animal Biotechnology Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
  • 6. Animal Biotechnology: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2022)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Roche Holding AG (Switzerland)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Bayer AG (Germany)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Biogenesis Bago (Argentina)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Boehringer Ingelheim (Germany)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Merck & Co., Inc. (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Pfizer Inc. (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Santa Cruz Biotechnology, Inc. (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Virbac (France)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Zoetis Inc. (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Johnson & Johnson (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Animal Biotechnology Sale, by Type, Application, Products and Region (value) (2023-2028)
    • 7.1. Introduction
    • 7.2. Global Animal Biotechnology (Value)
      • 7.2.1. Global Animal Biotechnology by: Type (Value)
        • 7.2.1.1. Animal Genomics
        • 7.2.1.2. Animal Cloning
        • 7.2.1.3. Genetic Engineering of Animals
      • 7.2.2. Global Animal Biotechnology by: Application (Value)
        • 7.2.2.1. Preventive Care for Animals
        • 7.2.2.2. Development of Animal Pharmaceuticals
        • 7.2.2.3. Food Safety and Drug Development
        • 7.2.2.4. Others
      • 7.2.3. Global Animal Biotechnology by: Products (Value)
        • 7.2.3.1. Animal Products
        • 7.2.3.2. Vaccines
        • 7.2.3.3. Drugs
        • 7.2.3.4. Others
      • 7.2.4. Global Animal Biotechnology Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Animal Biotechnology: by Type(USD Million)
  • Table 2. Animal Biotechnology Animal Genomics , by Region USD Million (2017-2022)
  • Table 3. Animal Biotechnology Animal Cloning , by Region USD Million (2017-2022)
  • Table 4. Animal Biotechnology Genetic Engineering of Animals , by Region USD Million (2017-2022)
  • Table 5. Animal Biotechnology: by Application(USD Million)
  • Table 6. Animal Biotechnology Preventive Care for Animals , by Region USD Million (2017-2022)
  • Table 7. Animal Biotechnology Development of Animal Pharmaceuticals , by Region USD Million (2017-2022)
  • Table 8. Animal Biotechnology Food Safety and Drug Development , by Region USD Million (2017-2022)
  • Table 9. Animal Biotechnology Others , by Region USD Million (2017-2022)
  • Table 10. Animal Biotechnology: by Products(USD Million)
  • Table 11. Animal Biotechnology Animal Products , by Region USD Million (2017-2022)
  • Table 12. Animal Biotechnology Vaccines , by Region USD Million (2017-2022)
  • Table 13. Animal Biotechnology Drugs , by Region USD Million (2017-2022)
  • Table 14. Animal Biotechnology Others , by Region USD Million (2017-2022)
  • Table 15. South America Animal Biotechnology, by Country USD Million (2017-2022)
  • Table 16. South America Animal Biotechnology, by Type USD Million (2017-2022)
  • Table 17. South America Animal Biotechnology, by Application USD Million (2017-2022)
  • Table 18. South America Animal Biotechnology, by Products USD Million (2017-2022)
  • Table 19. Brazil Animal Biotechnology, by Type USD Million (2017-2022)
  • Table 20. Brazil Animal Biotechnology, by Application USD Million (2017-2022)
  • Table 21. Brazil Animal Biotechnology, by Products USD Million (2017-2022)
  • Table 22. Argentina Animal Biotechnology, by Type USD Million (2017-2022)
  • Table 23. Argentina Animal Biotechnology, by Application USD Million (2017-2022)
  • Table 24. Argentina Animal Biotechnology, by Products USD Million (2017-2022)
  • Table 25. Rest of South America Animal Biotechnology, by Type USD Million (2017-2022)
  • Table 26. Rest of South America Animal Biotechnology, by Application USD Million (2017-2022)
  • Table 27. Rest of South America Animal Biotechnology, by Products USD Million (2017-2022)
  • Table 28. Asia Pacific Animal Biotechnology, by Country USD Million (2017-2022)
  • Table 29. Asia Pacific Animal Biotechnology, by Type USD Million (2017-2022)
  • Table 30. Asia Pacific Animal Biotechnology, by Application USD Million (2017-2022)
  • Table 31. Asia Pacific Animal Biotechnology, by Products USD Million (2017-2022)
  • Table 32. China Animal Biotechnology, by Type USD Million (2017-2022)
  • Table 33. China Animal Biotechnology, by Application USD Million (2017-2022)
  • Table 34. China Animal Biotechnology, by Products USD Million (2017-2022)
  • Table 35. Japan Animal Biotechnology, by Type USD Million (2017-2022)
  • Table 36. Japan Animal Biotechnology, by Application USD Million (2017-2022)
  • Table 37. Japan Animal Biotechnology, by Products USD Million (2017-2022)
  • Table 38. India Animal Biotechnology, by Type USD Million (2017-2022)
  • Table 39. India Animal Biotechnology, by Application USD Million (2017-2022)
  • Table 40. India Animal Biotechnology, by Products USD Million (2017-2022)
  • Table 41. South Korea Animal Biotechnology, by Type USD Million (2017-2022)
  • Table 42. South Korea Animal Biotechnology, by Application USD Million (2017-2022)
  • Table 43. South Korea Animal Biotechnology, by Products USD Million (2017-2022)
  • Table 44. Taiwan Animal Biotechnology, by Type USD Million (2017-2022)
  • Table 45. Taiwan Animal Biotechnology, by Application USD Million (2017-2022)
  • Table 46. Taiwan Animal Biotechnology, by Products USD Million (2017-2022)
  • Table 47. Australia Animal Biotechnology, by Type USD Million (2017-2022)
  • Table 48. Australia Animal Biotechnology, by Application USD Million (2017-2022)
  • Table 49. Australia Animal Biotechnology, by Products USD Million (2017-2022)
  • Table 50. Rest of Asia-Pacific Animal Biotechnology, by Type USD Million (2017-2022)
  • Table 51. Rest of Asia-Pacific Animal Biotechnology, by Application USD Million (2017-2022)
  • Table 52. Rest of Asia-Pacific Animal Biotechnology, by Products USD Million (2017-2022)
  • Table 53. Europe Animal Biotechnology, by Country USD Million (2017-2022)
  • Table 54. Europe Animal Biotechnology, by Type USD Million (2017-2022)
  • Table 55. Europe Animal Biotechnology, by Application USD Million (2017-2022)
  • Table 56. Europe Animal Biotechnology, by Products USD Million (2017-2022)
  • Table 57. Germany Animal Biotechnology, by Type USD Million (2017-2022)
  • Table 58. Germany Animal Biotechnology, by Application USD Million (2017-2022)
  • Table 59. Germany Animal Biotechnology, by Products USD Million (2017-2022)
  • Table 60. France Animal Biotechnology, by Type USD Million (2017-2022)
  • Table 61. France Animal Biotechnology, by Application USD Million (2017-2022)
  • Table 62. France Animal Biotechnology, by Products USD Million (2017-2022)
  • Table 63. Italy Animal Biotechnology, by Type USD Million (2017-2022)
  • Table 64. Italy Animal Biotechnology, by Application USD Million (2017-2022)
  • Table 65. Italy Animal Biotechnology, by Products USD Million (2017-2022)
  • Table 66. United Kingdom Animal Biotechnology, by Type USD Million (2017-2022)
  • Table 67. United Kingdom Animal Biotechnology, by Application USD Million (2017-2022)
  • Table 68. United Kingdom Animal Biotechnology, by Products USD Million (2017-2022)
  • Table 69. Netherlands Animal Biotechnology, by Type USD Million (2017-2022)
  • Table 70. Netherlands Animal Biotechnology, by Application USD Million (2017-2022)
  • Table 71. Netherlands Animal Biotechnology, by Products USD Million (2017-2022)
  • Table 72. Rest of Europe Animal Biotechnology, by Type USD Million (2017-2022)
  • Table 73. Rest of Europe Animal Biotechnology, by Application USD Million (2017-2022)
  • Table 74. Rest of Europe Animal Biotechnology, by Products USD Million (2017-2022)
  • Table 75. MEA Animal Biotechnology, by Country USD Million (2017-2022)
  • Table 76. MEA Animal Biotechnology, by Type USD Million (2017-2022)
  • Table 77. MEA Animal Biotechnology, by Application USD Million (2017-2022)
  • Table 78. MEA Animal Biotechnology, by Products USD Million (2017-2022)
  • Table 79. Middle East Animal Biotechnology, by Type USD Million (2017-2022)
  • Table 80. Middle East Animal Biotechnology, by Application USD Million (2017-2022)
  • Table 81. Middle East Animal Biotechnology, by Products USD Million (2017-2022)
  • Table 82. Africa Animal Biotechnology, by Type USD Million (2017-2022)
  • Table 83. Africa Animal Biotechnology, by Application USD Million (2017-2022)
  • Table 84. Africa Animal Biotechnology, by Products USD Million (2017-2022)
  • Table 85. North America Animal Biotechnology, by Country USD Million (2017-2022)
  • Table 86. North America Animal Biotechnology, by Type USD Million (2017-2022)
  • Table 87. North America Animal Biotechnology, by Application USD Million (2017-2022)
  • Table 88. North America Animal Biotechnology, by Products USD Million (2017-2022)
  • Table 89. United States Animal Biotechnology, by Type USD Million (2017-2022)
  • Table 90. United States Animal Biotechnology, by Application USD Million (2017-2022)
  • Table 91. United States Animal Biotechnology, by Products USD Million (2017-2022)
  • Table 92. Canada Animal Biotechnology, by Type USD Million (2017-2022)
  • Table 93. Canada Animal Biotechnology, by Application USD Million (2017-2022)
  • Table 94. Canada Animal Biotechnology, by Products USD Million (2017-2022)
  • Table 95. Mexico Animal Biotechnology, by Type USD Million (2017-2022)
  • Table 96. Mexico Animal Biotechnology, by Application USD Million (2017-2022)
  • Table 97. Mexico Animal Biotechnology, by Products USD Million (2017-2022)
  • Table 98. Company Basic Information, Sales Area and Its Competitors
  • Table 99. Company Basic Information, Sales Area and Its Competitors
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Company Basic Information, Sales Area and Its Competitors
  • Table 108. Animal Biotechnology: by Type(USD Million)
  • Table 109. Animal Biotechnology Animal Genomics , by Region USD Million (2023-2028)
  • Table 110. Animal Biotechnology Animal Cloning , by Region USD Million (2023-2028)
  • Table 111. Animal Biotechnology Genetic Engineering of Animals , by Region USD Million (2023-2028)
  • Table 112. Animal Biotechnology: by Application(USD Million)
  • Table 113. Animal Biotechnology Preventive Care for Animals , by Region USD Million (2023-2028)
  • Table 114. Animal Biotechnology Development of Animal Pharmaceuticals , by Region USD Million (2023-2028)
  • Table 115. Animal Biotechnology Food Safety and Drug Development , by Region USD Million (2023-2028)
  • Table 116. Animal Biotechnology Others , by Region USD Million (2023-2028)
  • Table 117. Animal Biotechnology: by Products(USD Million)
  • Table 118. Animal Biotechnology Animal Products , by Region USD Million (2023-2028)
  • Table 119. Animal Biotechnology Vaccines , by Region USD Million (2023-2028)
  • Table 120. Animal Biotechnology Drugs , by Region USD Million (2023-2028)
  • Table 121. Animal Biotechnology Others , by Region USD Million (2023-2028)
  • Table 122. South America Animal Biotechnology, by Country USD Million (2023-2028)
  • Table 123. South America Animal Biotechnology, by Type USD Million (2023-2028)
  • Table 124. South America Animal Biotechnology, by Application USD Million (2023-2028)
  • Table 125. South America Animal Biotechnology, by Products USD Million (2023-2028)
  • Table 126. Brazil Animal Biotechnology, by Type USD Million (2023-2028)
  • Table 127. Brazil Animal Biotechnology, by Application USD Million (2023-2028)
  • Table 128. Brazil Animal Biotechnology, by Products USD Million (2023-2028)
  • Table 129. Argentina Animal Biotechnology, by Type USD Million (2023-2028)
  • Table 130. Argentina Animal Biotechnology, by Application USD Million (2023-2028)
  • Table 131. Argentina Animal Biotechnology, by Products USD Million (2023-2028)
  • Table 132. Rest of South America Animal Biotechnology, by Type USD Million (2023-2028)
  • Table 133. Rest of South America Animal Biotechnology, by Application USD Million (2023-2028)
  • Table 134. Rest of South America Animal Biotechnology, by Products USD Million (2023-2028)
  • Table 135. Asia Pacific Animal Biotechnology, by Country USD Million (2023-2028)
  • Table 136. Asia Pacific Animal Biotechnology, by Type USD Million (2023-2028)
  • Table 137. Asia Pacific Animal Biotechnology, by Application USD Million (2023-2028)
  • Table 138. Asia Pacific Animal Biotechnology, by Products USD Million (2023-2028)
  • Table 139. China Animal Biotechnology, by Type USD Million (2023-2028)
  • Table 140. China Animal Biotechnology, by Application USD Million (2023-2028)
  • Table 141. China Animal Biotechnology, by Products USD Million (2023-2028)
  • Table 142. Japan Animal Biotechnology, by Type USD Million (2023-2028)
  • Table 143. Japan Animal Biotechnology, by Application USD Million (2023-2028)
  • Table 144. Japan Animal Biotechnology, by Products USD Million (2023-2028)
  • Table 145. India Animal Biotechnology, by Type USD Million (2023-2028)
  • Table 146. India Animal Biotechnology, by Application USD Million (2023-2028)
  • Table 147. India Animal Biotechnology, by Products USD Million (2023-2028)
  • Table 148. South Korea Animal Biotechnology, by Type USD Million (2023-2028)
  • Table 149. South Korea Animal Biotechnology, by Application USD Million (2023-2028)
  • Table 150. South Korea Animal Biotechnology, by Products USD Million (2023-2028)
  • Table 151. Taiwan Animal Biotechnology, by Type USD Million (2023-2028)
  • Table 152. Taiwan Animal Biotechnology, by Application USD Million (2023-2028)
  • Table 153. Taiwan Animal Biotechnology, by Products USD Million (2023-2028)
  • Table 154. Australia Animal Biotechnology, by Type USD Million (2023-2028)
  • Table 155. Australia Animal Biotechnology, by Application USD Million (2023-2028)
  • Table 156. Australia Animal Biotechnology, by Products USD Million (2023-2028)
  • Table 157. Rest of Asia-Pacific Animal Biotechnology, by Type USD Million (2023-2028)
  • Table 158. Rest of Asia-Pacific Animal Biotechnology, by Application USD Million (2023-2028)
  • Table 159. Rest of Asia-Pacific Animal Biotechnology, by Products USD Million (2023-2028)
  • Table 160. Europe Animal Biotechnology, by Country USD Million (2023-2028)
  • Table 161. Europe Animal Biotechnology, by Type USD Million (2023-2028)
  • Table 162. Europe Animal Biotechnology, by Application USD Million (2023-2028)
  • Table 163. Europe Animal Biotechnology, by Products USD Million (2023-2028)
  • Table 164. Germany Animal Biotechnology, by Type USD Million (2023-2028)
  • Table 165. Germany Animal Biotechnology, by Application USD Million (2023-2028)
  • Table 166. Germany Animal Biotechnology, by Products USD Million (2023-2028)
  • Table 167. France Animal Biotechnology, by Type USD Million (2023-2028)
  • Table 168. France Animal Biotechnology, by Application USD Million (2023-2028)
  • Table 169. France Animal Biotechnology, by Products USD Million (2023-2028)
  • Table 170. Italy Animal Biotechnology, by Type USD Million (2023-2028)
  • Table 171. Italy Animal Biotechnology, by Application USD Million (2023-2028)
  • Table 172. Italy Animal Biotechnology, by Products USD Million (2023-2028)
  • Table 173. United Kingdom Animal Biotechnology, by Type USD Million (2023-2028)
  • Table 174. United Kingdom Animal Biotechnology, by Application USD Million (2023-2028)
  • Table 175. United Kingdom Animal Biotechnology, by Products USD Million (2023-2028)
  • Table 176. Netherlands Animal Biotechnology, by Type USD Million (2023-2028)
  • Table 177. Netherlands Animal Biotechnology, by Application USD Million (2023-2028)
  • Table 178. Netherlands Animal Biotechnology, by Products USD Million (2023-2028)
  • Table 179. Rest of Europe Animal Biotechnology, by Type USD Million (2023-2028)
  • Table 180. Rest of Europe Animal Biotechnology, by Application USD Million (2023-2028)
  • Table 181. Rest of Europe Animal Biotechnology, by Products USD Million (2023-2028)
  • Table 182. MEA Animal Biotechnology, by Country USD Million (2023-2028)
  • Table 183. MEA Animal Biotechnology, by Type USD Million (2023-2028)
  • Table 184. MEA Animal Biotechnology, by Application USD Million (2023-2028)
  • Table 185. MEA Animal Biotechnology, by Products USD Million (2023-2028)
  • Table 186. Middle East Animal Biotechnology, by Type USD Million (2023-2028)
  • Table 187. Middle East Animal Biotechnology, by Application USD Million (2023-2028)
  • Table 188. Middle East Animal Biotechnology, by Products USD Million (2023-2028)
  • Table 189. Africa Animal Biotechnology, by Type USD Million (2023-2028)
  • Table 190. Africa Animal Biotechnology, by Application USD Million (2023-2028)
  • Table 191. Africa Animal Biotechnology, by Products USD Million (2023-2028)
  • Table 192. North America Animal Biotechnology, by Country USD Million (2023-2028)
  • Table 193. North America Animal Biotechnology, by Type USD Million (2023-2028)
  • Table 194. North America Animal Biotechnology, by Application USD Million (2023-2028)
  • Table 195. North America Animal Biotechnology, by Products USD Million (2023-2028)
  • Table 196. United States Animal Biotechnology, by Type USD Million (2023-2028)
  • Table 197. United States Animal Biotechnology, by Application USD Million (2023-2028)
  • Table 198. United States Animal Biotechnology, by Products USD Million (2023-2028)
  • Table 199. Canada Animal Biotechnology, by Type USD Million (2023-2028)
  • Table 200. Canada Animal Biotechnology, by Application USD Million (2023-2028)
  • Table 201. Canada Animal Biotechnology, by Products USD Million (2023-2028)
  • Table 202. Mexico Animal Biotechnology, by Type USD Million (2023-2028)
  • Table 203. Mexico Animal Biotechnology, by Application USD Million (2023-2028)
  • Table 204. Mexico Animal Biotechnology, by Products USD Million (2023-2028)
  • Table 205. Research Programs/Design for This Report
  • Table 206. Key Data Information from Secondary Sources
  • Table 207. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Animal Biotechnology: by Type USD Million (2017-2022)
  • Figure 5. Global Animal Biotechnology: by Application USD Million (2017-2022)
  • Figure 6. Global Animal Biotechnology: by Products USD Million (2017-2022)
  • Figure 7. South America Animal Biotechnology Share (%), by Country
  • Figure 8. Asia Pacific Animal Biotechnology Share (%), by Country
  • Figure 9. Europe Animal Biotechnology Share (%), by Country
  • Figure 10. MEA Animal Biotechnology Share (%), by Country
  • Figure 11. North America Animal Biotechnology Share (%), by Country
  • Figure 12. Global Animal Biotechnology share by Players 2022 (%)
  • Figure 13. Global Animal Biotechnology share by Players (Top 3) 2022(%)
  • Figure 14. Global Animal Biotechnology share by Players (Top 5) 2022(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. Roche Holding AG (Switzerland) Revenue, Net Income and Gross profit
  • Figure 17. Roche Holding AG (Switzerland) Revenue: by Geography 2022
  • Figure 18. Bayer AG (Germany) Revenue, Net Income and Gross profit
  • Figure 19. Bayer AG (Germany) Revenue: by Geography 2022
  • Figure 20. Biogenesis Bago (Argentina) Revenue, Net Income and Gross profit
  • Figure 21. Biogenesis Bago (Argentina) Revenue: by Geography 2022
  • Figure 22. Boehringer Ingelheim (Germany) Revenue, Net Income and Gross profit
  • Figure 23. Boehringer Ingelheim (Germany) Revenue: by Geography 2022
  • Figure 24. Merck & Co., Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 25. Merck & Co., Inc. (United States) Revenue: by Geography 2022
  • Figure 26. Pfizer Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 27. Pfizer Inc. (United States) Revenue: by Geography 2022
  • Figure 28. Santa Cruz Biotechnology, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 29. Santa Cruz Biotechnology, Inc. (United States) Revenue: by Geography 2022
  • Figure 30. Virbac (France) Revenue, Net Income and Gross profit
  • Figure 31. Virbac (France) Revenue: by Geography 2022
  • Figure 32. Zoetis Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 33. Zoetis Inc. (United States) Revenue: by Geography 2022
  • Figure 34. Johnson & Johnson (United States) Revenue, Net Income and Gross profit
  • Figure 35. Johnson & Johnson (United States) Revenue: by Geography 2022
  • Figure 36. Global Animal Biotechnology: by Type USD Million (2023-2028)
  • Figure 37. Global Animal Biotechnology: by Application USD Million (2023-2028)
  • Figure 38. Global Animal Biotechnology: by Products USD Million (2023-2028)
  • Figure 39. South America Animal Biotechnology Share (%), by Country
  • Figure 40. Asia Pacific Animal Biotechnology Share (%), by Country
  • Figure 41. Europe Animal Biotechnology Share (%), by Country
  • Figure 42. MEA Animal Biotechnology Share (%), by Country
  • Figure 43. North America Animal Biotechnology Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Roche Holding AG (Switzerland)
  • Bayer AG (Germany)
  • Biogenesis Bago (Argentina)
  • Boehringer Ingelheim (Germany)
  • Merck & Co., Inc. (United States)
  • Pfizer Inc. (United States)
  • Santa Cruz Biotechnology, Inc. (United States)
  • Virbac (France)
  • Zoetis Inc. (United States)
  • Johnson & Johnson (United States)
Select User Access Type

Key Highlights of Report


Jun 2023 218 Pages 74 Tables Base Year: 2022 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Animal Biotechnology Quantitative research analysis
Global Animal Biotechnology Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

"Increased Applications of the Animal Biotechnology in Various Fields " is seen as one of major growth factors of Animal Biotechnology Market in years to come.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
The Animal Biotechnology market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete of companies available in our research coverage.

Know More About Global Animal Biotechnology Report?

Have a Query? Click Here

Other Related Reports

Bioproducts Comprehensive Study by Type (Conventional Bioproducts, Emerging Bioproducts), Application (Building Materials, Pulp and Paper, Forest Products, Medical, Energy, Chemical Industry, Agricul...
$ 3650
Stable Isotopes Labelled Compounds Comprehensive Study by Type (Carbon-13, Nitrogen-15, Oxygen-18, Deuterium, Other Isotopes), Application (Research {Biomedical Research, Pharmaceutical Research, Env...
$ 3750
Botanical Extracts Comprehensive Study by Type (Hydrosols, Alcohol Tinctures, CO2 extracts, Glycerites, Powdered Extracts, Others), Application (Food {Bakery & Confectionery, Sauces & Dressings}, Bev...
$ 3750
Cytology and HPV Testing Comprehensive Study by Type (Systems, Assay Kits, Services), Application (Cervical Cancer Screening Test, Head and Neck Cancer Screening Test, Molecular Diagnostics, Research...
$ 3650
Bare Metal Stents Comprehensive Study by Type (Balloon Catheter, Self-Expandable Metallic Stent, Balloon Expandable Stent), Application (Large Vessel, Small Vessel), End Users (Hospitals, Ambulatory ...
$ 3450
Cold Plasma Comprehensive Study by Application (Surface Treatment, Sterilization & Disinfection, Coating, Finishing, Adhesion, Wound Healing, Others), Regime (Atmospheric Cold Plasma, Low-Pressure Co...
$ 3750